Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1400107	重组抗VEGF人源化单克隆抗体Fab注射液	ranibizumab	Injection	Biological Products(15)	New Drug Application	2014-12-09	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	Certificate Issued	2016-09-04	view
CXSL1400109	重组抗VEGF人源化单克隆抗体Fab注射液	ranibizumab	Injection	Biological Products(15)	New Drug Application	2014-12-09	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	Certificate Issued	2016-09-04	view
CXSL1400108	重组抗VEGF人源化单克隆抗体Fab注射液	ranibizumab	Injection	Biological Products(15)	New Drug Application	2014-12-09	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	Certificate Issued	2016-09-04	view